ahlam1399
01-29-2016, 07:09 PM
UPDATE 2-AbbVie quarterly revenue misses estimates, shares fall
Jan 29 (Reuters) – Cost cuts helped U.S. drugmaker Abbvie Inc report slightly better-than-expected fourth-quarter earnings on Friday, but shares slipped nearly 3 percent as revenue fell short of expectations for a second time in the past eight quarters.
http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/1/rc.img (http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/1/rc.htm)
http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/2/rc.img (http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/2/rc.htm)
http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/3/rc.img (http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/3/rc.htm)
http://da.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/a2.img (http://da.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/a2.htm)
http://adchoice.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/ach.img (http://adchoice.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/ach.htm)http://pi.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/a2t.imghttp://pi2.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4d390b3c/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=cNw6skTYH-0:w78g4Xvn3Jw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=cNw6skTYH-0:w78g4Xvn3Jw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=cNw6skTYH-0:w78g4Xvn3Jw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=cNw6skTYH-0:w78g4Xvn3Jw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=cNw6skTYH-0:w78g4Xvn3Jw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/cNw6skTYH-0
Jan 29 (Reuters) – Cost cuts helped U.S. drugmaker Abbvie Inc report slightly better-than-expected fourth-quarter earnings on Friday, but shares slipped nearly 3 percent as revenue fell short of expectations for a second time in the past eight quarters.
http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/1/rc.img (http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/1/rc.htm)
http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/2/rc.img (http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/2/rc.htm)
http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/3/rc.img (http://rc.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/rc/3/rc.htm)
http://da.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/a2.img (http://da.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/a2.htm)
http://adchoice.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/ach.img (http://adchoice.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/ach.htm)http://pi.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/a2t.imghttp://pi2.feedsportal.com/r/247389775003/u/49/f/654213/c/35217/s/4d390b3c/sc/24/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4d390b3c/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=cNw6skTYH-0:w78g4Xvn3Jw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=cNw6skTYH-0:w78g4Xvn3Jw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=cNw6skTYH-0:w78g4Xvn3Jw:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=cNw6skTYH-0:w78g4Xvn3Jw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=cNw6skTYH-0:w78g4Xvn3Jw:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/cNw6skTYH-0